Funding boycotts are ‘irresponsible, entitled and childish’
The debate over whether artists should accept funding from Baillie Gifford has reignited again as leading figures in the theatre community have waded into a row over whether to accept…
The debate over whether artists should accept funding from Baillie Gifford has reignited again as leading figures in the theatre community have waded into a row over whether to accept…
The City minister doubled down on the government’s collision course with regulators today as he laid out a choice between “high regulatory barriers” and making the Square Mile “competitive” on…
A cohort of British supermarkets are reportedly planning to join forces to buy ethically sourced food such as bananas, coffee and cocoa from farmers in developing countries, entering talks with…
Xander Schauffele has set his sights on a successful defence of his Olympic title after winning a first major in record-breaking fashion at the US PGA Championship on Sunday. Schauffele…
Getir, the rapid grocery delivery firm with plans to depart the UK, has a multimillion pound outstanding debt to Premier League giants Tottenham Hotspur Football Club. The Turkish firm, which…
Ben Broadbent, a deputy governor at the Bank of England, said today that it was “possible” that interest would be cut this summer, in line with market expectations. “If things…
There is a growing trend of litigation-focused law firms setting up in the City, which includes Quillon Law, a City-based firm set up by partners Mark Hastings and Michael Barnett.…
Listed law firm Knights reported double-digit profit growth over the last final year while its revenue rose by nearly £8m. On Monday the firm said its full year revenue for…
A man of the match performance from FTI’s Oliver Harrison laid the foundation for a 3-0 victory for the City’s PRs in their annual battle with journalists, a scoreline that…
Astrazeneca has said it would invest $1.5bn (£1.2bn) to build a manufacturing facility in Singapore to produce antibody drug conjugates (ADCs), a next-generation cancer treatment. The FTSE 100 firm announced…